Kherachi, R.; Ismail, D.; Mettai, M.; Hasni, F.; Nadjib, M.
Studying the Inhibitory Activity of Novel Series Compounds for Parkinson’s Disease Using a Molecular Docking Method. Proceedings 2024, 103, 56.
https://doi.org/10.3390/proceedings2024103056
AMA Style
Kherachi R, Ismail D, Mettai M, Hasni F, Nadjib M.
Studying the Inhibitory Activity of Novel Series Compounds for Parkinson’s Disease Using a Molecular Docking Method. Proceedings. 2024; 103(1):56.
https://doi.org/10.3390/proceedings2024103056
Chicago/Turabian Style
Kherachi, Rania, Daoud Ismail, Merzaka Mettai, Ferdaous Hasni, and Melkemi Nadjib.
2024. "Studying the Inhibitory Activity of Novel Series Compounds for Parkinson’s Disease Using a Molecular Docking Method" Proceedings 103, no. 1: 56.
https://doi.org/10.3390/proceedings2024103056
APA Style
Kherachi, R., Ismail, D., Mettai, M., Hasni, F., & Nadjib, M.
(2024). Studying the Inhibitory Activity of Novel Series Compounds for Parkinson’s Disease Using a Molecular Docking Method. Proceedings, 103(1), 56.
https://doi.org/10.3390/proceedings2024103056